AAN DMT guideline
American Academy of Neurology
Addresses starting, switching, and stopping DMT through shared decisions, adherence, reproductive plans, activity, and safety.
Read registered sourceTreatment
Contents
Multiple sclerosis treatment combines disease-modifying therapy with relapse care, rehabilitation, and symptom management. No single treatment addresses every part of MS, and a plan usually changes as disease activity, life goals, health conditions, and available evidence change.
Treatment selection integrates inflammatory activity, disease course, prognostic features, safety, monitoring, and patient priorities. It should not be reduced to a universal ranking of medicines because risk and benefit differ substantially among individuals.
Guideline patch notes
ECTRIMS/EAN guideline
ECTRIMS and European Academy of Neurology
Links treatment choice and escalation to disease activity, efficacy, adverse effects, and monitoring.
Read registered source NICE NG220
National Institute for Health and Care Excellence
Integrates relapse care, symptom treatment, rehabilitation, information, and coordinated multidisciplinary management.
Read registered sourceDisease-modifying therapy
Section titled “Disease-modifying therapy”Disease-modifying therapy reduces the probability of new inflammatory activity. Options differ by route, mechanism, expected efficacy, infection and immune risks, reproductive considerations, monitoring, reversibility, and access. Shared decision-making should include what happens if treatment is delayed, ineffective, poorly tolerated, interrupted, or stopped.
Relapse treatment
Section titled “Relapse treatment”Selected functionally significant relapses may be treated with high-dose corticosteroids after infection and alternative explanations are considered. Steroids can speed recovery from an attack but do not substitute for DMT and do not necessarily change the eventual degree of recovery. Severe attacks may require hospital-level assessment or additional specialist treatment.
Rehabilitation and symptom management
Section titled “Rehabilitation and symptom management”Physical, occupational, speech, cognitive, and vocational rehabilitation can address mobility, balance, upper-limb function, communication, swallowing, energy conservation, cognition, and participation. Symptom care may address spasticity, pain, fatigue, mood, sleep, bladder or bowel dysfunction, sexual health, tremor, and walking.
Monitoring and prevention
Section titled “Monitoring and prevention”Monitoring combines clinical review, MRI, laboratory testing, treatment-specific safety surveillance, vaccination and infection planning, preventive care, and pregnancy or contraception discussions when relevant. New symptoms should not automatically trigger a medicine change without determining their cause.
Clinical detail
Section titled “Clinical detail”Treatment strategy includes both efficacy and treatment burden. Escalation, early high-efficacy treatment, de-escalation, switching, and discontinuation each have different evidence and risks; the correct discussion depends on current inflammatory activity and individual context.